Open-label study of craving in smokers with schizophrenia using nicotine nasal spray compared to nicotine patch

Journal of Dual Diagnosis

Volumn 4, Issue 4, 2008, Pages 355-376

  Williams, Jill M ^a,b   Gandhi, Kunal K ^a,b   Karavidas, Maria Katsamanis ^a   Steinberg, Marc L ^a   Lu, Shou En ^b   Foulds, Jonathan ^a,b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Craving; Cue reactivity; Nicotine nasal spray; Nicotine replacement; Schizophrenia; Smoking cessation

Indexed keywords

NICOTINE; NICOTINE PATCH;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; SMOKING; SMOKING CESSATION; TREATMENT RESPONSE; VISUAL ANALOG SCALE; WITHDRAWAL SYNDROME;

EID: 71049165621     PISSN: 15504263     EISSN: 15504271     Source Type: Journal    
DOI: 10.1080/15504260802085919     Document Type: Article

References (68)

1. Abrams, D. B., Monti, P. M., Carey, K. B., Pinto, R. P., & Jacobus, S. I. (1988). Reactivity to smoking cues and relapse: Two studies of discriminant validity. Behavior Research and Therapy, 26(3), 225-233.
2. Addington, J. (1998). Group treatment for smoking cessation among persons with schizophrenia. Psychiatric Services, 49(7), 925-928. (Pubitemid 28311521)
3. Adler, L. E., Hoffer, L. D., Wiser, A., & Freedman, R. (1993). Normalization of auditory physiology by cigarette smoking in schizophrenic patients. American Journal of Psychiatry, 150, 1856-1861. (Pubitemid 23356580)
4. Benowitz, N. L., Zevin, S., & Jacob, P. 3rd. (1997). Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. British Journal of Clinical Pharmacology, 43(3), 259-267.
5. Bernardi, L., Porta, C., Gabutti, A., Spicuzza, L., & Sleight, P. (2001). Modulatory effects of respiration. Autonomic Neuroscience, 90(1-2), 47-56.
6. Bernardi, L., Porta, C., Spicuzza, L., Bellwon, J., Spadacini, G., Frey, A. W., et al. (2002). Slow breathing increases arterial baroreflex sensitivity in patients with chronic heart failure. Circulation, 105(2), 143-145.
7. Breese, C. R., Lee, M. J., Adams, C. E., Sullivan, B., Logel, J., Gillen, K. M., et al. (2000). Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology, 23(4), 351-364.
8. Carter, B. L., & Tiffany, S. T. (1999).Meta-analysis of cue-reactivity in addiction research. Addiction, 94(3), 327-340.
9. Carter, B. L.,&Tiffany, S. T. (2001). The cue-availability paradigm: The effects of cigarette availability on cue reactivity in smokers. Experimental and Clinical Psychopharmacology, 9(2), 183-190.
10. Chambers, R. A., Krystal, J. H.,&Self, D.W. (2001). A neurobiological basis for substance abuse comorbidity in schizophrenia. Biological Psychiatry, 50(2), 71-83.
11. Childress, A. R., Hole, A. V., Ehrman, R. N., Robbins, S. J., McLellan, A. T., & O'Brien, C. P. (1993). Cue reactivity and cue reactivity interventions in drug dependence. NIDA Research Monograph, 137, 73-95.
12. Conklin, C. A., & Tiffany, S. T. (2001). The impact of imagining personalized versus standardized urge scenarios on cigarette craving and autonomic reactivity. Experimental and Clinical Psychopharmacology, 9(4), 399-408.
13. de Leon, J., Abraham, G., Nair, C., Verghese, C., McGrory, A.,&McCann, E. (1995). Nicotine addiction in chronic schizophrenic inpatients. Biological Psychiatry, 37, 593-683.
14. Drobes, D. J., & Tiffany, S. T. (1997). Induction of smoking urge through imaginal and in vivo procedures: Physiological and self-report manifestations. Journal of Abnormal Psychology, 106(1), 15-25.
15. Droungas, A., Ehrman, R. N., Childress, A. R., & O'Brien, C. P. (1995). Effect of smoking cues and cigarette availability on craving and smoking behavior. Addictive Behaviors, 20(5), 657-673.
16. Ehrman, R. N., Robbins, S. J., Childress, A. R., & O'Brien, C. P. (1992). Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology, 107, 523-529.
17. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-Mental State: A practical method for grading the state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
18. Fonder, M. A., Sacco, K. A., Termine, A., Boland, B. S., Seyal, A. A., Dudas, M. M., et al. (2005). Smoking cue reactivity in schizophrenia: Effects of a nicotinic receptor antagonist. Biological Psychiatry, 57(7), 802-808.
19. Freedman, R., Adams, C. E., & Leonard, S. (2000). The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia. Journal of Chemical Neuroanatomy, 20, 299-306.
20. Glautier, S. & Tiffany, S. T. (1995). Methodological issues in cue reactivity research. In D. C. Drummond, S. T. Tiffany, G. Glautier, & B. Remington (Eds.), Addictive behaviour: Cue exposure theory and practice. New York: John Wiley & Sons.
21. Griffith, J. M., O'Neill, J. E., Petty, F., Garver, D., Young, D., & Freedman, R. (1998). Nicotinic receptor desensitization and sensory gating deficits in schizophrenia. Biological Psychiatry, 44(2), 98-106.
22. Hajek, P.,West, R., Foulds, J., Nilsson, F., Burrows, S., &Meadow, A. (1999). Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray and an inhaler. Archives of Internal Medicine, 159, 2033-2038.
23. Halamek, J., Kara, T., Jurak, P., Soucek, M., Francis, D. P., Davies, L. C., et al. (2003). Variability of phase shift between blood pressure and heart rate fluctuations: A marker of short-term circulation control. Circulation, 108(3), 292-297.
24. Heil, S. H., Tidey, J.W., Holmes,H.W., Badger, G. J.,&Higgins, S. T. (2003).Acontingent payment model of smoking cessation: Effects on abstinence and withdrawal. Nicotine & Tobacco Research, 5(2), 205-213.
25. Hjalmarson, A., Franzon, M., Westin, A., & Wiklund, O. (1994). Effect of nicotine nasal spray on smoking cessation. Archives of Internal Medicine, 154(28), 2567-2572.
26. Hughes, J. R., Hatsukami, D. K., Mitchell, J. E., & Dahlgren, L. A. (1996). Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry, 143, 993-997.
27. Hurt, R. D., Dale, L. C., Croghan, G. A., Croghan, I. T., Gomez-Dahl, L. C., & Offord, K. P. (1998). Nicotine nasal spray for smoking cessation: Pattern of use, side effects,relief of withdrawal symptoms, and cotinine levels. Mayo Clinic Proceedings, 73(2), 118-125.
28. JimenezRuiz, C. A., FlorezMartin, S., Ramos Pineda,A., Lorza, J. J.,Hernandez-Mezquita, M. A., Solano Reina, S., et al. (1999). Nasal nicotine spray in smoking cessation. Results of a multicenter study. Archives of Broncopneumologia, 35(11), 535-538.
29. Jones, R. L., Nguyen, A., &Man, S. F. P. (1998). Nicotine and cotinine when nicotine nasal spray is used to quit smoking. Psychopharmacology, 137, 345-350.
30. Lazev, A. B.,Herzog, T. A.,&Brandon, T. H. (1999). Classical conditions of environmental cues to cigarette smoking. Experimental and Clinical Psychopharmacology, 7(1), 56-63.
31. Marlatt, G. A. (1990). Cue exposure and relapse prevention in the treatment of addictive behaviors. Addictive Behaviors, 15(4), 395-399.
32. Maude-Griffin, P. M., & Tiffany, S. T. (1996). The production of smoking urges through imagery: The impact of affect and smoking abstinence. Experimental and Clinical Psychopharmacology, 4, 198-208.
33. Niaura, R., Abrams, D., Demuth, B., Pinto, R., & Monti, P. (1989). Responses to smokingrelated stimuli and early relapse to smoking. Addictive Behaviors, 14(4), 419-428.
34. Niaura, R., Abrams, D. B., Pedraza, M., Monti, P. M., & Rohsenow, D. J. (1992). Smokers' reactions to interpersonal interaction and presentation of smoking cues. Addictive Behaviors, 17(6), 557-566.
35. Niaura, R., Shadel, W. G., Abrams, D. B., Monti, P. M., Rohsenow, D. J., & Sirota, A. (1998). Individual differences in cue reactivity among smokers trying to quit: Effects of gender and cue type. Addictive Behaviors, 23(2), 209-224.
36. Olincy, A., Ross, R. G., Young, D. A., Roath, M., & Freedman, R. (1998). Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuropsychopharmacology, 18(3), 175-185.
37. Perkins, K. A., Lerman, C., Keenan, J., Fonte, C.,&Coddington, S. (2004). Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers. Nicotine & Tobacco Research, 6(3), 501-507.
38. Rickard-Figueroa, K.,&Zeichner, A. (1985).Assessment of smoking urge and its concomitants under an environmental smoking cue manipulation. Addictive Behaviors, 10(3), 249-256.
39. Rohsenow, D. J., & Niaura, R. S. (1999). Reflections on the state of cue-reactivity theories and research. Addiction, 94(3), 343-344.
40. Rose, J. E., Herskovic, J. E., Trilling, Y., & Jarvik, M. E. (1985). Transdermal nicotine reduces cigarette craving and nicotine preference. Clinical Pharmacology & Therapeutics, 38, 450-456.
41. Russell, M. A. H., Jarvis, M. J., Feyerabend, C.,&Ferno, O. (1983).Nasal nicotine solution: A potential aid to giving up smoking. British Medical Journal (Clinical Research Ed.), 286, 683-684.
42. Sayette, M. A., & Hufford, M. R. (1994). Effects of cue exposure and deprivation on cognitive resources in smokers. Journal of Abnormal Psychology, 103(4), 812-818.
43. Sayette, M. A., Shiffman, S., Tiffany, S. T., Niaura, R. S., Martin, C. S., & Shadel, W. G. (2000). The measurement of drug craving. Addiction, 95(Supplement 2), S189-S210.
44. Schneider, M. P., van Melle, G., Uldry, C., Huynh-Ba, M., Fallab Stubi, C. L., Iorillo, D., t al. (2003). Electronic monitoring of long-term use of the nicotine nasal spray andpredictors of success in a smoking cessation program. Nicotine & Tobacco Research, 5(5), 719-727.
45. Schneider, N. G., Olmstead, R., Mody, F. V., Doaan, K., Franzon, M., Jarvik, M. A., et al. (1995). Efficacy of a nicotine nasal spray in smoking cessation: A placebo-controlled, double blind trial. Addiction, 90, 1671-1682.
46. Shadel,W. G., Niaura, R.,&Abrams, D. B. (2001). Effect of different cue stimulus delivery channels on craving reactivity: Comparing in vivo and video cues in regular cigarette smokers. Journal of Behavior Therapy & Experimental Psychiatry, 32(4), 203-209.
47. Sherr, J. D., Myers, C., Avila, M. T., Elliott, A., Blaxton, T. A., & Thaker, G. K. (2002). The effects of nicotine on specific eye tracking measures in schizophrenia. Biological Psychiatry, 52(7), 721-728.
48. Shiffman, S. (2000). Comments on craving. Addiction, 95(Supplement 2), S171-S175.
49. Shiffman, S., Elash, C. A., Paton, S. M., Gwaltney, C. J., Paty, J. A., Clark, D. B., et al. (2000). Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving. Addiction, 95(8), 1185-1195.
50. Shiffman, S., Paty, J. A., Gnys, M., Kassel, J. A., & Hickcox, M. (1996). First lapses to smoking:Within-subjects analysis of real-time reports. Journal of Consulting & Clinical Psychology, 64(2), 366-379.
51. Shiffman, S., Shadel, W. G., Niaura, R., Khayrallah, M. A., Jorenby, D. E., Ryan, C. F., et al. (2003). Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving. Psychopharmacology (Berlin), 166(4), 343-350.
52. Silagy, C., Lancaster, T., Stead, L., Mant, D., & Fowler, G. (2004). Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews, 3, CD000146.
53. Smelson, D. A., Losonczy, M. F., Kilker, C., Starosta, A., Kind, J., Williams, J., et al. (2002). An analysis of cue reactivity among persons with and without schizophrenia who are addicted to cocaine. Psychiatric Services, 53, 1612-1616.
54. Song, H. S., & Lehrer, P. M. (2003). The effects of specific respiratory rates on heart rate and heart rate variability. Applied Psychophysiology & Biofeedback, 28(1), 13-23.
55. Sutherland, G., Russell, M. A. H., Stapleton, J., Feyerabend, C., & Ferno, O. (1992). Nasal nicotine spray: A rapid nicotine delivery system. Psychopharmacology, 108, 512-518.
56. Sutherland, G., Stapleton, J. A., Russell, M. A., Jarvis, M. J., Hajek, P., Belcher, M., et al. (1992). Randomized controlled trial of nicotine nasal spray in smoking cessation. Lancet, 340, 324-329.
57. Tidey, J. W., O'Neill, S. C., & Higgins, S. T. (2002). Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia. Experimental & Clinical Psychopharmacology, 10(3), 241-247.
58. Tidey, J. W., Rohsenow, D. J., Kaplan, G. B., & Swift, R. M. (2005). Subjective and physiological responses to smoking cues in smokers with schizophrenia. Nicotine & Tobacco Research, 7(3), 1-9.
59. Tidey, J. W. & Williams, J. M. (2007). Clinical indices of tobacco use in people with schizophrenia. Journal of Dual Diagnosis, 3(3/4), 79-98.
60. Tiffany, S. T. (1990). A cognitive model of drug urges and drug-use behavior: Role of automatic and nonautomatic processes. Psychological Review, 97(2), 147-168.
61. Tiffany, S. T., Cox, L. S., & Elash, C. A. (2000). Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers. Journal of Consulting & Clinical Psychology, 68(2), 233-240.
62. Waters, A. J., Shiffman, S., Sayette,M. A., Paty, J. A., Gwaltney, C. J., & Balabanis,M. H. (2004). Cue-provoked craving and nicotine replacement therapy in smoking cessation. Journal of Consulting & Clinical Psychology, 72(6), 1136-1143.
63. West, R., Hajek, P., Foulds, J., Nilsson, F., May, S., & Meadows, A. (2000). A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacology, 149, 198-202.
64. Williams, J. M., & Foulds, J. (2007). Successful tobacco dependence treatment in schizophrenia. American Journal of Psychiatry, 164(2), 222-227.
65. Williams, J. M. & Hughes, J. R. (2003). Pharmacotherapy treatments for tobacco dependence among smokers with mental illness or addiction. Psychiatric Annals, 22(7), 457-466.
66. Williams, J. M., Ziedonis, D. M., Abanyie, F., Steinberg, M. L., Foulds, J., & Benowitz, N. L. (2005). Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophrenia Research, 79(2-3), 323-335.
67. Williams, J. M., Ziedonis, D. M., & Foulds, J. (2004). A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia. Psychiatric Services, 55(9), 1064-1066.
68. Ziedonis, D. M., & George, T. P. (1997). Schizophrenia and nicotine use: Report of a pilot smoking cessation program and of neurobiological and clinical issues. Schizophrenia Bulletin, 23(2), 247-254.